Silencing RNA to treat heart failure and cardiomyopathy

9 May 2026 (08:00 - 12:45)

Organised by:

About the speaker

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

3 More presentations in this session

Presentation thumbnail

Targets for gene therapy in heart failure and cardiomyopathies

Doctor R. Hajjar (Boston, US)

Presentation thumbnail

Gene therapy targeting cardiac remodelling in heart failure and cardiomyopathies

Associate Professor A. Gonzalez Miqueo (Pamplona, ES)

Presentation thumbnail

Updates in gene therapy in heart failure and cardiomyopathies - discussion

Access the full session

Session thumbnail

Updates in gene therapy in heart failure and cardiomyopathies

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Medical treatment works! Contemporary implementation into clinical practice

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources